Brittany D Needham1, Mark D Adame2, Gloria Serena3, Destanie R Rose4, Gregory M Preston5, Mary C Conrad5, A Stewart Campbell5, David H Donabedian5, Alessio Fasano3, Paul Ashwood4, Sarkis K Mazmanian6. 1. Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California. Electronic address: bneedham@caltech.edu. 2. Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California. 3. Division of Pediatric Gastroenterology and Nutrition, Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, Massachusetts. 4. Department of Medical Microbiology and Immunology, University of California, Davis, Davis, California; MIND Institute, University of California, Davis, Sacramento, California. 5. Axial Biotherapeutics, Waltham, Massachusetts. 6. Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California. Electronic address: sarkis@caltech.edu.
Abstract
BACKGROUND: Autism spectrum disorder (ASD) is a neurodevelopmental condition with hallmark behavioral manifestations including impaired social communication and restricted repetitive behavior. In addition, many affected individuals display metabolic imbalances, immune dysregulation, gastrointestinal dysfunction, and altered gut microbiome compositions. METHODS: We sought to better understand nonbehavioral features of ASD by determining molecular signatures in peripheral tissues through mass spectrometry methods (ultrahigh performance liquid chromatography-tandem mass spectrometry) with broad panels of identified metabolites. Herein, we compared the global metabolome of 231 plasma and 97 fecal samples from a large cohort of children with ASD and typically developing control children. RESULTS: Differences in amino acid, lipid, and xenobiotic metabolism distinguished ASD and typically developing samples. Our results implicated oxidative stress and mitochondrial dysfunction, hormone level elevations, lipid profile changes, and altered levels of phenolic microbial metabolites. We also revealed correlations between specific metabolite profiles and clinical behavior scores. Furthermore, a summary of metabolites modestly associated with gastrointestinal dysfunction in ASD is provided, and a pilot study of metabolites that can be transferred via fecal microbial transplant into mice is identified. CONCLUSIONS: These findings support a connection between metabolism, gastrointestinal physiology, and complex behavioral traits and may advance discovery and development of molecular biomarkers for ASD.
BACKGROUND: Autism spectrum disorder (ASD) is a neurodevelopmental condition with hallmark behavioral manifestations including impaired social communication and restricted repetitive behavior. In addition, many affected individuals display metabolic imbalances, immune dysregulation, gastrointestinal dysfunction, and altered gut microbiome compositions. METHODS: We sought to better understand nonbehavioral features of ASD by determining molecular signatures in peripheral tissues through mass spectrometry methods (ultrahigh performance liquid chromatography-tandem mass spectrometry) with broad panels of identified metabolites. Herein, we compared the global metabolome of 231 plasma and 97 fecal samples from a large cohort of children with ASD and typically developing control children. RESULTS: Differences in amino acid, lipid, and xenobiotic metabolism distinguished ASD and typically developing samples. Our results implicated oxidative stress and mitochondrial dysfunction, hormone level elevations, lipid profile changes, and altered levels of phenolic microbial metabolites. We also revealed correlations between specific metabolite profiles and clinical behavior scores. Furthermore, a summary of metabolites modestly associated with gastrointestinal dysfunction in ASD is provided, and a pilot study of metabolites that can be transferred via fecal microbial transplant into mice is identified. CONCLUSIONS: These findings support a connection between metabolism, gastrointestinal physiology, and complex behavioral traits and may advance discovery and development of molecular biomarkers for ASD.
Authors: Alan M Smith; Joseph J King; Paul R West; Michael A Ludwig; Elizabeth L R Donley; Robert E Burrier; David G Amaral Journal: Biol Psychiatry Date: 2018-09-06 Impact factor: 13.382
Authors: Christopher Gillberg; Elisabeth Fernell; Eva Kočovská; Helen Minnis; Thomas Bourgeron; Lucy Thompson; Clare S Allely Journal: Autism Res Date: 2017-04-12 Impact factor: 5.216
Authors: A Stewart Campbell; Brittany D Needham; Christopher R Meyer; Joanna Tan; Mary Conrad; Gregory M Preston; Federico Bolognani; Srinivas G Rao; Helen Heussler; Rebecca Griffith; Adam J Guastella; Amy C Janes; Blaise Frederick; David H Donabedian; Sarkis K Mazmanian Journal: Nat Med Date: 2022-02-14 Impact factor: 53.440
Authors: Ying Dong; Pan Wang; Junling Lin; Chunming Han; Jie Jiao; Kun Zuo; Mulei Chen; Xinchun Yang; Jun Cai; He Jiang; Xiheng Guo; Jing Li Journal: J Clin Sleep Med Date: 2022-02-01 Impact factor: 4.062
Authors: Janelle E Stanton; Sigita Malijauskaite; Kieran McGourty; Andreas M Grabrucker Journal: Front Mol Neurosci Date: 2021-07-05 Impact factor: 5.639
Authors: Patricia Bermudez-Martin; Jérôme A J Becker; Nicolas Caramello; Sebastian P Fernandez; Renan Costa-Campos; Juliette Canaguier; Susana Barbosa; Laura Martinez-Gili; Antonis Myridakis; Marc-Emmanuel Dumas; Aurélia Bruneau; Claire Cherbuy; Philippe Langella; Jacques Callebert; Jean-Marie Launay; Joëlle Chabry; Jacques Barik; Julie Le Merrer; Nicolas Glaichenhaus; Laetitia Davidovic Journal: Microbiome Date: 2021-07-08 Impact factor: 14.650